logo

Tiziana Life Sciences Plc (TLSA)



Trade TLSA now with
  Date
  Headline
9/23/2022 7:12:18 AM Tiziana Life Sciences Announces Purchase Of 75K Shares At $0.83/Shr By Chief Medical Officer Matthew Davis
4/5/2022 7:16:43 AM FDA Permitsto Enroll 8 Addl SPMS Patients In Expanded Access Program With Intranasal Foralumab
9/2/2021 2:25:01 AM Precision BioSciences, Tiziana Life Sciences To Evaluate Foralumab With Allogeneic CAR T Candidates For Cancer Treatment
8/20/2021 3:53:32 AM Tiziana Life Sciences To Delist From LSE
6/23/2021 3:42:27 AM Tiziana Agrees With FHI Clinical To Conduct Phase 2 Clinical Trial For COVID-19 Patients With Intranasal Foralumab
6/21/2021 2:36:16 AM Tiziana Appoints Kevin Schutz As VP Of Regulatory Affairs
1/13/2021 2:34:13 AM Tiziana Life Sciences Appoints Neil Graham Chief Medical Officer